Ocumension Therapeutics Stock OTC Markets
Stocks
OCUTF
KYG674111011
Pharmaceuticals
OTC Markets Traded|
Market Closed -
OTC Markets
09:34:31 2026-06-08 EDT
|
5-day change | 1st Jan Change | ||
| 0.7000 USD | -.--% |
|
-.--% | - |
| 08-28 | Ocumension Therapeutics Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
| 08-10 | Nicox Sa and Ocumension Therapeutics Submit Ncx 470 New Drug Application in China | CI |
| Market Cap | 3.71B 551M 475M 445M 407M 766M 52.68B 768M 5.28B 2.06B 26.59B 2.07B 2.02B 88.18B | P/E 2026 * |
114x | P/E 2027 * | 31.4x |
|---|---|---|---|---|---|
| Enterprise Value | 3.52B 523M 451M 422M 386M 726M 49.97B 729M 5.01B 1.96B 25.22B 1.96B 1.92B 83.63B | EV / Sales 2026 * |
3.18x | EV / Sales 2027 * | 2.57x |
| Free-Float |
41.36% | Yield 2026 * |
-
| Yield 2027 * | - |
| Current year | 0.7 |  | 0.7 |
| 1 year | 0.7 | | 0.7 |
| 3 years | 0.7 | | 0.7 |
| 5 years | 0.7 | | 0.7 |
| 10 years | 0.7 | | 0.7 |
| Manager | Title | Age | Since |
|---|---|---|---|
Ye Liu
CEO | Chief Executive Officer | 54 | 2018-07-31 |
Yang Shen
CTO | Chief Tech/Sci/R&D Officer | 43 | 2023-12-31 |
Zhao Peng Hu
LAW | General Counsel | 53 | 2018-09-02 |
| Director | Title | Age | Since |
|---|---|---|---|
Ye Liu
BRD | Director/Board Member | 54 | 2018-11-22 |
Zhao Peng Hu
BRD | Director/Board Member | 53 | 2020-04-23 |
Yan Ling Cao
BRD | Director/Board Member | 42 | 2019-06-17 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -.--% | - | - | 551M | |
| -0.13% | -6.44% | +60.47% | +112.05% | 1,047B | |
| +0.85% | -0.81% | +52.77% | +63.15% | 646B | |
| -1.03% | -3.58% | +22.87% | +73.29% | 451B | |
| -1.46% | -4.50% | +37.43% | +38.41% | 355B | |
| -0.72% | -2.89% | +21.86% | +36.79% | 291B | |
| -1.19% | -2.21% | +1.35% | +12.29% | 252B | |
| -1.05% | -1.57% | +51.40% | +68.55% | 234B | |
| +0.08% | -1.78% | -17.64% | -54.29% | 203B | |
| -2.14% | -0.30% | +29.42% | +89.10% | 181B | |
| Average | -0.69% | -2.68% | +28.88% | +48.82% | 406.59B | |
| Weighted average by Cap. | -0.48% | -3.46% | +38.66% | +65.51% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1.1B 164M 141M 133M 121M 228M 15.69B 229M 1.57B 614M 7.92B 616M 603M 26.26B | 1.42B 212M 182M 171M 156M 294M 20.23B 295M 2.03B 792M 10.21B 795M 778M 33.87B |
| Net income | 31.83M 4.73M 4.08M 3.82M 3.49M 6.57M 452M 6.59M 45.35M 17.69M 228M 17.76M 17.38M 757M | 122M 18.06M 15.56M 14.59M 13.32M 25.1M 1.73B 25.18M 173M 67.55M 871M 67.82M 66.34M 2.89B |
| Net Debt | -191M -28.39M -24.47M -22.94M -20.94M -39.45M -2.71B -39.58M -272M -106M -1.37B -107M -104M -4.54B | -51.13M -7.6M -6.55M -6.14M -5.6M -10.56M -726M -10.59M -72.85M -28.42M -367M -28.53M -27.91M -1.22B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 1477 Stock
- OCUTF Stock
Select your edition
All financial news and data tailored to specific country editions
